\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ testicular\\ lump\\.\\ nontender\\ to\\ palpation\\.\\ no\\ scrotal\\ skin\\ changes\\.\\ no\\ palpable\\ lymph\\ nodes\\.\ \(0\)\
\-\ afp\\,\\ testosterone\\,\\ bhcg\\,\\ and\\ ldh\\ were\\ all\\ witnin\\ normal\\ limits\\.\ \(0\)\
\-\ patient\\ was\\ treated\\ by\\ radical\\ orchiectomy\\.\\ subsequent\\ imaging\\ was\\ negative\\ for\\ evidence\\ of\\ metastatic\\ disease\\.\ \(0\)\
\-\ testicular\\ ultrasound\\ demonstrate\\ 2\\ well\\-defined\\ hypoechoic\\,\\ hypervascular\\ lesions\\ in\\ the\\ left\\ testis\\ as\\ well\\ as\\ diffuse\\ microlithiases\\.\\ one\\ of\\ the\\ lesions\\ abuts\\ the\\ tunica\\ albuginea\\ with\\ direct\\ invasion\\ not\\ excluded\\.\ \(0\)\
\-\ seminoma\\ \\-\\ dx\\ path\\ proven\\.\ \(0\)\
\-\ seminoma\ \(37\)\
\-\ embryonal\\ tumor\ \(0\)\
\-\ yolk\\ sac\\ tumor\ \(8\)\
\-\ non\\-germ\\ cell\\ tumor\ \(0\)\
\-\ metastasis\ \(206\)\
\-\ a\\ 47\\ year\\-old\\ male\\ with\\ a\\ history\\ of\\ oligospermia\\ and\\ testicular\\ atrophy\\ presents\\ with\\ concern\\ of\\ a\\ lump\\ in\\ his\\ left\\ testicle\\.\\ prior\\ ultrasounds\\ had\\ been\\ significant\\ solely\\ for\\ numerous\\,\\ bilateral\\ microlithiases\\.\\ his\\ past\\ medical\\ history\\ includes\\ malignant\\ melanoma\\ greater\\ than\\ ten\\ years\\ ago\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ microlithiases\\:\\ 0\\.3220896666617748\ \(0\)\
\-\ testicular\\:\\ 0\\.2833266573710388\ \(0\)\
\-\ seminoma\\:\\ 0\\.22103366858289847\ \(0\)\
\-\ lump\\:\\ 0\\.21062515324468897\ \(0\)\
\-\ witnin\\:\\ 0\\.1610448333308874\ \(0\)\
\-\ oligospermia\\:\\ 0\\.1610448333308874\ \(0\)\
\-\ tumor\\:\\ 0\\.1580193707315594\ \(0\)\
\-\ albuginea\\:\\ 0\\.1365718200585634\ \(0\)\
\-\ solely\\:\\ 0\\.1326325447891072\ \(0\)\
\-\ testosterone\\:\\ 0\\.13094998200824545\ \(0\)\
\-\ tunica\\:\\ 0\\.12941392253658304\ \(0\)\
\-\ ultrasounds\\:\\ 0\\.12547464726712682\ \(0\)\
\-\ bhcg\\:\\ 0\\.12326507378502402\ \(0\)\
\-\ abuts\\:\\ 0\\.12326507378502402\ \(0\)\
\-\ his\\:\\ 0\\.12214698366758527\ \(0\)\
\-\ ten\\:\\ 0\\.12039603815294517\ \(0\)\
\-\ embryonal\\:\\ 0\\.11792874407266778\ \(0\)\
\-\ yolk\\:\\ 0\\.11576437816313645\ \(0\)\
\-\ lesions\\:\\ 0\\.11566889809970242\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.11509812749262234\ \(0\)\
\-\ dx\\:\\ 0\\.11323814063096482\ \(0\)\
\-\ radical\\:\\ 0\\.11155557785010307\ \(0\)\
\-\ path\\:\\ 0\\.11155557785010307\ \(0\)\
\-\ ldh\\:\\ 0\\.10953582928775425\ \(0\)\
\-\ testis\\:\\ 0\\.10906504012269978\ \(0\)\
\-\ scrotal\\:\\ 0\\.10647696873592143\ \(0\)\
\-\ hypervascular\\:\\ 0\\.10647696873592143\ \(0\)\
\-\ afp\\:\\ 0\\.10608024310898446\ \(0\)\
\-\ left\\:\\ 0\\.10305520946115723\ \(0\)\
\-\ proven\\:\\ 0\\.10160011664565993\ \(0\)\
\-\ testicle\\:\\ 0\\.10129833925536093\ \(0\)\
\-\ excluded\\:\\ 0\\.09905359933246224\ \(0\)\
\-\ well\\:\\ 0\\.09752105939452392\ \(0\)\
\-\ atrophy\\:\\ 0\\.09527312765957828\ \(0\)\
\-\ nontender\\:\\ 0\\.0948527852432438\ \(0\)\
\-\ melanoma\\:\\ 0\\.0940409848650129\ \(0\)\
\-\ 47\\:\\ 0\\.0923403990632475\ \(0\)\
\-\ concern\\:\\ 0\\.0923403990632475\ \(0\)\
\-\ invasion\\:\\ 0\\.08982617483364344\ \(0\)\
\-\ sac\\:\\ 0\\.08967063596455743\ \(0\)\
\-\ direct\\:\\ 0\\.0887651273586408\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.08604382101912522\ \(0\)\
\-\ nodes\\:\\ 0\\.08554650510611665\ \(0\)\
\-\ numerous\\:\\ 0\\.08506281601543023\ \(0\)\
\-\ as\\:\\ 0\\.08091134192124069\ \(0\)\
\-\ limits\\:\\ 0\\.07957158433722497\ \(0\)\
\-\ of\\:\\ 0\\.07882794456816287\ \(0\)\
\-\ lymph\\:\\ 0\\.07830706680433112\ \(0\)\
\-\ includes\\:\\ 0\\.07830706680433112\ \(0\)\
\-\ history\\:\\ 0\\.07694818449089655\ \(0\)\
\-\ subsequent\\:\\ 0\\.07623681990630334\ \(0\)\
\-\ skin\\:\\ 0\\.07491305440700537\ \(0\)\
\-\ greater\\:\\ 0\\.07418971664405007\ \(0\)\
\-\ metastasis\\:\\ 0\\.0738073143829632\ \(0\)\
\-\ ago\\:\\ 0\\.07368166582804012\ \(0\)\
\-\ malignant\\:\\ 0\\.07178415812878991\ \(0\)\
\-\ palpable\\:\\ 0\\.07074702097146954\ \(0\)\
\-\ was\\:\\ 0\\.07019146775598528\ \(0\)\
\-\ palpation\\:\\ 0\\.06791247789064236\ \(0\)\
\-\ past\\:\\ 0\\.06554953230069993\ \(0\)\
\-\ no\\:\\ 0\\.06549445681253058\ \(0\)\
\-\ medical\\:\\ 0\\.06400031327014132\ \(0\)\
\-\ diffuse\\:\\ 0\\.06315278024159132\ \(0\)\
\-\ treated\\:\\ 0\\.06271014159152666\ \(0\)\
\-\ negative\\:\\ 0\\.06234407942397622\ \(0\)\
\-\ ultrasound\\:\\ 0\\.06211502184142106\ \(0\)\
\-\ years\\:\\ 0\\.06172913658783167\ \(0\)\
\-\ for\\:\\ 0\\.061044163025087944\ \(0\)\
\-\ changes\\:\\ 0\\.060860245354574745\ \(0\)\
\-\ the\\:\\ 0\\.06028124809346374\ \(0\)\
\-\ all\\:\\ 0\\.059945654926915275\ \(0\)\
\-\ with\\:\\ 0\\.059156283184694014\ \(0\)\
\-\ been\\:\\ 0\\.05867027603599884\ \(0\)\
\-\ significant\\:\\ 0\\.05814326533475776\ \(0\)\
\-\ one\\:\\ 0\\.057656769861831624\ \(0\)\
\-\ cell\\:\\ 0\\.057606331120542975\ \(0\)\
\-\ evidence\\:\\ 0\\.057158752422965434\ \(0\)\
\-\ than\\:\\ 0\\.057085246914512174\ \(0\)\
\-\ prior\\:\\ 0\\.056343090210533936\ \(0\)\
\-\ metastatic\\:\\ 0\\.055230150909636684\ \(0\)\
\-\ bilateral\\:\\ 0\\.05412110940864538\ \(0\)\
\-\ imaging\\:\\ 0\\.05292244452375765\ \(0\)\
\-\ demonstrate\\:\\ 0\\.05235231271071288\ \(0\)\
\-\ were\\:\\ 0\\.05190910414095544\ \(0\)\
\-\ had\\:\\ 0\\.050173567434546526\ \(0\)\
\-\ in\\:\\ 0\\.05010290712686592\ \(0\)\
\-\ presents\\:\\ 0\\.04844298409380144\ \(0\)\
\-\ male\\:\\ 0\\.04483651906121839\ \(0\)\
\-\ by\\:\\ 0\\.0427640191739578\ \(0\)\
\-\ disease\\:\\ 0\\.04227123039200155\ \(0\)\
\-\ and\\:\\ 0\\.041617777404505\ \(0\)\
\-\ normal\\:\\ 0\\.04111605666515302\ \(0\)\
\-\ not\\:\\ 0\\.03975485596425223\ \(0\)\
\-\ patient\\:\\ 0\\.03275338912782207\ \(0\)\
\-\ to\\:\\ 0\\.025175366666023154\ \(0\)\
